Ramy Ibrahim
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 39
- Cancer Immunotherapy and Biomarkers 31
- CAR-T cell therapy research 16
- Immunology 21
- Immunotherapy and Immune Responses 13
- Co-authors
- Axel Hoos (11 shared papers)Rachel Humphrey (5 shared papers)Michele Maio (21 shared papers)Hubert Pehamberger (4 shared papers)Steven O’Day (5 shared papers)J. D. Wolchok (3 shared papers)Jedd D. Wolchok (7 shared papers)Samir N. Khleif (7 shared papers)
- Journals
- Journal of Clinical Oncology (20 papers)Blood (5 papers)European Journal of Cancer (5 papers)Cancer Immunology Immunotherapy (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)
- Partner nations
- United StatesItalyBelgium
In The Last Decade
Ramy Ibrahim
62 papers receiving 2.4k citations
Ramy Ibrahim's Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 1.8k
- Immunology 971
- Pulmonary and Respiratory Medicine 363
- Genetics 106
- Cancer Research 95
Countries citing papers authored by Ramy Ibrahim
This map shows the geographic impact of Ramy Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramy Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramy Ibrahim more than expected).
Fields of papers citing papers by Ramy Ibrahim
This network shows the impact of papers produced by Ramy Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramy Ibrahim. The network helps show where Ramy Ibrahim may publish in the future.
Co-authors
The 25 scholars most cited alongside Ramy Ibrahim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study Hit paper breakdown → | 2010 | 415 |
| 2 | 2010 | 374 | |
| 3 | 2010 | 199 | |
| 4 | 2014 | 138 | |
| 5 | 2011 | 135 | |
| 6 | Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials. | 2010 | 95 |
| 7 | 2014 | 85 | |
| 8 | 2010 | 84 | |
| 9 | 2015 | 77 | |
| 10 | 2009 | 74 | |
| 11 | 2014 | 64 | |
| 12 | 2009 | 49 | |
| 13 | 2011 | 48 | |
| 14 | 2009 | 35 | |
| 15 | 2008 | 33 | |
| 16 | 2008 | 33 | |
| 17 | 2022 | 32 | |
| 18 | 2016 | 31 | |
| 19 | 2020 | 28 | |
| 20 | 2010 | 26 |
About Ramy Ibrahim
Ramy Ibrahim is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Genetics, having authored 66 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (31 papers), CAR-T cell therapy research (16 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), Immunotherapy and Immune Responses (13 papers), Chronic Lymphocytic Leukemia Research (9 papers), Occupational and environmental lung diseases (6 papers), Acute Lymphoblastic Leukemia research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (1.8k citations), Immunology (971 citations), Pulmonary and Respiratory Medicine (363 citations), Genetics (106 citations) and Cancer Research (95 citations). Ramy Ibrahim has collaborated with scholars based in United States, Italy and Belgium. Frequent co-authors include Axel Hoos, Rachel Humphrey, Michele Maio, Hubert Pehamberger, Steven O’Day, J. D. Wolchok, Jedd D. Wolchok, Samir N. Khleif, Veerle de Pril and Alexander Eggermont. Their work appears in journals such as Journal of Clinical Oncology, Blood, European Journal of Cancer, Cancer Immunology Immunotherapy and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.